Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

When should I be screening my canine patients for cancer?

Monday, January 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article features Dr. Heather Wilson-Robles discussing the importance of screening canine patients for cancer. It highlights the introduction of the Nu.Q® Vet Cancer Test and mentions a forthcoming publication that could unlock a significant financial milestone for Volition. The content emphasizes proactive health measures in veterinary care.
Price reaction · baseline $20.6 (2024-01-22T15:13:00.000Z) · hit during market hours · 12 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Expert insights from Dr. Heather Wilson-Robles on canine cancer screening.
  • Introduction of Nu.Q® Vet Cancer Test for early detection.
  • Potential for significant milestone payment with publication of research.

Full Press Release Details

Watch our short video, featuring Volition Veterinary Chief Medical Officer, Dr. Heather Wilson-Robles, to find out when you should be screening your patients for canine cancer.

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

Who is Dr. Heather Wilson-Robles?

Dr. Heather Wilson-Robles is the Chief Medical Officer at Volition Veterinary.

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is an automated test designed for early cancer detection in pets.

What milestone payment is mentioned?

A $5 million milestone payment is expected upon publication of a related study.

Why is screening for canine cancer important?

Early screening can lead to timely diagnosis and better treatment outcomes for dogs.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare canine cancer Nu.Q® Vet Cancer Test veterinary health Volition Dr. Heather Wilson-Robles
Last updated: Jan 22, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk